Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation

NCT01542138 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Hyperpigmentation

Interventions

DRUG: Desonide
DRUG: Niacinamide
DRUG: Placebo

Sponsor

Universidad Autonoma de San Luis Potosí

Collaborators

[object Object]